Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines

J. E. Crafford, C. W. Lourens, T. K. Smit, Ian Gardner, Nigel J Maclachlan, A. J. Guthrie

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

African horse sickness (AHS) is typically a highly fatal disease in susceptible horses and vaccination is currently used to prevent the occurrence of disease in endemic areas. Similarly, vaccination has been central to the control of incursions of African horse sickness virus (AHSV) into previously unaffected areas and will likely play a significant role in any future incursions. Horses in the AHSV-infected area in South Africa are vaccinated annually with a live-attenuated (modified-live virus [MLV]) vaccine, which includes a cocktail of serotypes 1, 3, 4 (bottle 1) and 2, 6-8 (bottle 2) delivered in two separate doses at least 21 days apart. In this study, the neutralising antibody response of foals immunized with this polyvalent MLV AHSV vaccine was evaluated and compared to the response elicited to monovalent MLV AHSV serotypes. Naïve foals were immunized with either the polyvalent MLV AHSV vaccine, or a combination of monovalent MLV vaccines containing individual AHSV serotypes 1, 4, 7 or 8. There was a marked and consistent difference in the immunogenicity of individual virus serotypes contained in the MLV vaccines. Specifically, foals most consistently seroconverted to AHSV-1 and responses to other serotypes were highly variable, and often weak or not detected. The serotype-specific responses of foals given the monovalent MLV vaccines were similar to those of foals given the polyvalent MLV preparation suggesting that there is no obvious enhanced immune response through the administration of a monovalent vaccine as opposed to the polyvalent vaccine.

Original languageEnglish (US)
Pages (from-to)3611-3616
Number of pages6
JournalVaccine
Volume32
Issue number29
DOIs
StatePublished - Jun 17 2014

Keywords

  • African horse sickness virus
  • Modified-live virus vaccine
  • Neutralizing antibody
  • Vaccination

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine
  • Medicine(all)

Fingerprint Dive into the research topics of 'Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines'. Together they form a unique fingerprint.

  • Cite this